ORMP Oramed Pharmaceuticals Inc.

Oramed Pharmaceuticals Inc is a pharmaceutical company. The Company is engaged in the research and development of pharmaceutical solutions, including an orally ingestible insulin capsule or tablet.

$10.50  -0.44 (-4.02%)
As of 05/10/2021 15:59:59 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  02/11/2013
Outstanding shares:  30,228,421
Average volume:  425,391
Market cap:   $321,025,831
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    68403P203
ISIN:        US68403P2039
Sedol:      B97LZ58
Valuation   (See tab for details)
PE ratio:   -14.48
PB ratio:   6.26
PS ratio:   118.85
Return on equity:   -31.26%
Net income %:   -572.31%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy